China's Sinopharm debuts new vaccines targeting COVID-19 variants

China's Sinopharm debuts new vaccines targeting COVID-19 variants

For more:
https://news.cgtn.com/news/2021-09-05/China-s-Sinopharm-debuts-new-vaccines-targeting-COVID-19-variants-13iTddS05yM/index.html

China's National Pharmaceutical Group Corporation (Sinopharm) unveiled a series of newly-developed COVID-19 vaccines and medicines at the 2021 China International Fair for Trade in Services (CIFTIS) on Saturday. Sinopharm have developed vaccines against coronavirus' Delta and Beta variants, said Zhu Jingjin, a project chief of Sinopharm, said at the fair. And its second-generation broad-spectrum recombinant protein vaccine is in trials, he added. The group said that it will expand its annual productivity to more than five billion doses in a bid to make China's COVID-19 vaccines global public goods. #China #Vaccine

Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv

CGTNNewsChina

Post a Comment

0 Comments